Simtra Adds $250M Sterile Manufacturing Facility to Indiana Campus
Key Points
- Simtra BioPharma Solutions opened a $250 million, 150,000-square-foot sterile manufacturing facility in Bloomington, Indiana, expanding its 600,000-square-foot campus.
- The facility features high-speed isolator-based syringe filling lines and multiple 30-square-meter lyophilizers for freeze-drying sterile injectable medicines.
- The expansion generated approximately 450 jobs as demand grows for specialized sterile drug production and injectable therapies.
Simtra BioPharma Solutions has opened a new $250 million manufacturing facility in Bloomington, Indiana, expanding its capacity for sterile injectable drug production. The 150,000-square-foot building, which began construction in June 2024, adds to the company’s existing 600,000-square-foot Bloomington campus. The project has also generated approximately 450 jobs, according to the company.
The facility is designed to support the development and manufacturing of sterile injectable medicines. Its equipment includes high-speed isolator-based syringe filling lines and multiple 30-square-meter lyophilizers for freeze-drying operations. The expansion increases Simtra’s manufacturing footprint as demand continues for specialized sterile drug production and injectable therapies.
Visit www.simtra.com for more information.
Total Page Views: 5
